Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogencontaining bisphosphonates on osteoclast precursors
- 1 January 2002
- Vol. 30 (1) , 64-70
- https://doi.org/10.1016/s8756-3282(01)00655-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI-298Journal of Bone and Mineral Research, 2000
- Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate SynthaseArchives of Biochemistry and Biophysics, 2000
- Mechanism of Aminobisphosphonate Action: Characterization of Alendronate Inhibition of the Isoprenoid PathwayBiochemical and Biophysical Research Communications, 1999
- Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitroProceedings of the National Academy of Sciences, 1999
- Geranylgeraniol Overcomes the Block of Cell Proliferation by Lovastatin in C6 Glioma CellsJournal of Neurochemistry, 1998
- Bisphosphonates: Mechanisms of ActionEndocrine Reviews, 1998
- Clodronate and Liposome-Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′-(β,γ-Dichloromethylene) Triphosphate, by Mammalian Cells In VitroJournal of Bone and Mineral Research, 1997
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.Journal of Clinical Investigation, 1989
- In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes.The Journal of Experimental Medicine, 1982